How to Help Your Patients Find Tazorac in Stock: A Provider's Guide

Prescribing tazarotene is only half the equation. The other half — ensuring your patient can actually fill the prescription — is increasingly part of effective dermatology practice. With insurance barriers, brand stocking variability, and price sensitivity all in play, a practical system for supporting access can meaningfully improve adherence and outcomes.

This guide is designed for dermatologists, primary care physicians, nurse practitioners, and physician assistants who prescribe tazarotene and want practical, actionable tools to help patients successfully fill their prescriptions.

Step 1: Prescribe Generic Tazarotene by Default

Unless there is a documented formulation-specific clinical reason (which is rare for most patients), write "tazarotene" on the prescription — not "Tazorac." Ensure the DAW (dispense as written) box is unchecked.

Generic tazarotene cream and gel are bioequivalent to brand-name Tazorac, widely available at major pharmacy chains, and dramatically less expensive. Brand-name Tazorac retail pricing of $250–$600 per tube creates significant barriers; generic tazarotene with a discount card runs $40–$80 per tube.

Step 2: Be Specific About Formulation and Strength

Tazarotene comes in multiple formulations. When prescribing, specify:

Cream vs. gel: Cream is preferred for dry or sensitive skin; gel for oily or acne-prone skin. For psoriasis, cream can be applied to any area; gel is limited to 20% BSA.

Strength: Start at 0.05% for most patients; step up to 0.1% if tolerated and needed.

Quantity: 30g for facial acne or limited psoriatic plaques; 100g for larger body surface areas.

The more precisely you specify formulation, the less confusion there is at the pharmacy — and the fewer callbacks your staff receives.

Step 3: Address Insurance Barriers Before the Patient Leaves the Office

Insurance is the most common reason tazarotene prescriptions go unfilled. Proactively address this at the point of prescribing:

Run a real-time benefits check through your EHR or pharmacy benefit manager to see if tazarotene requires PA before you send the prescription.

Submit PA proactively if you know the patient's plan requires it. A pre-emptive PA avoids treatment delays.

Provide a bridge prescription for tretinoin or adapalene while PA is pending for tazarotene. Patients shouldn't go weeks with untreated acne or psoriasis waiting for insurance approval.

Step 4: Equip Patients to Find In-Stock Pharmacies

Even with a valid prescription and insurance approval, patients may encounter pharmacies that don't have their specific tazarotene strength in stock. Set expectations and provide solutions:

Tell patients upfront: "Your pharmacy may need to order this — call ahead to confirm stock before you go."

Recommend that patients try CVS, Walgreens, Walmart Pharmacy, or Kroger-affiliated pharmacies, which typically have the best generic dermatology medication coverage.

Direct patients to medfinder, which calls pharmacies on the patient's behalf and texts them which ones have their medication in stock.

Step 5: Set Realistic Counseling Expectations

Inadequate counseling on what to expect from tazarotene leads to premature discontinuation. Before patients fill their first prescription, cover:

Initial irritation ("retinization") is normal. Redness, peeling, and dryness in the first 2–4 weeks is expected and generally subsides as skin adjusts.

Results take time. Acne improvement typically takes 8–12 weeks; psoriasis plaque reduction 4–12 weeks.

Apply at night, use sunscreen daily. Tazarotene significantly increases photosensitivity; daily broad-spectrum SPF 30+ is non-negotiable.

Use a moisturizer. Applying a bland, fragrance-free moisturizer 15–30 minutes before tazarotene ("short-contact" technique) reduces irritation without reducing efficacy.

When to Consider Alternatives or Compounding

If a patient has exhausted in-network pharmacy options and mail order, compounding pharmacies can formulate tazarotene cream or gel at custom concentrations. This is especially useful for patients who need an intermediate strength (e.g., 0.025%) not commercially available.

To learn more about supporting patient access through medfinder, visit medfinder for providers.